Integrated Advisors Network’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,137	Closed	-$224K	–	726
2025 Q3	$224K	Sell	4,137 -930	-18%	-$53.2K	0.01%	724
2025 Q2	$279K	Buy	5,067 +1,067	+27%	+$62.8K	0.01%	639
2025 Q1	$283K	Buy	4,000 +876	+28%	+$58.9K	0.01%	598
2024 Q4	$205K	Sell	3,124 -2,138	-41%	-$143K	0.01%	667
2024 Q3	$370K	Buy	5,262 +1,876	+55%	+$157K	0.02%	548
2024 Q2	$279K	Sell	3,386 -53	-2%	-$4.41K	0.01%	585
2024 Q1	$300K	Sell	3,439 -94	-3%	-$8.41K	0.02%	599
2023 Q4	$341K	Buy	3,533 +206	+6%	+$18.2K	0.02%	525
2023 Q3	$294K	Buy	3,327 +25	+0.8%	+$2.22K	0.02%	545
2023 Q2	$286K	Hold	3,302	–	–	0.02%	556
2023 Q1	$321K	Buy	3,302 +130	+4%	+$13.5K	0.02%	530
2022 Q4	$328K	Buy	+3,172	New	+$298K	0.02%	497